Your browser doesn't support javascript.
loading
Non-Invasive Delivery of Insulin for Breaching Hindrances against Diabetes.
Sarangi, Manoj; Padhi, Sasmita; Rath, Goutam.
Afiliação
  • Sarangi M; Amity University, Lucknow Campus.
  • Padhi S; Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Malhaur Railway Station Road, Gomti Nagar, Lucknow, Uttar Pradesh, Pin-201313, India.
  • Rath G; Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan University, Bhubaneswar-751030, Odisha, India.
Article em En | MEDLINE | ID: mdl-38608132
ABSTRACT
Insulin is recognized as a crucial weapon in managing diabetes. Subcutaneous (s.c.) injections are the traditional approach for insulin administration, which usually have many limitations. Numerous alternative (non-invasive) slants through different routes have been explored by the researchers for making needle-free delivery of insulin for attaining its augmented absorption as well as bioavailability. The current review delineating numerous pros and cons of several novel approaches of non-invasive insulin delivery by overcoming many of their hurdles. Primary information on the topic was gathered by searching scholarly articles from PubMed added with extraction of data from auxiliary manuscripts. Many approaches (discussed in the article) are meant for the delivery of a safe, effective, stable, and patient friendly administration of insulin via buccal, oral, inhalational, transdermal, intranasal, ocular, vaginal and rectal routes. Few of them have proven their clinical efficacy for maintaining the glycemic levels, whereas others are under the investigational pipe line. The developed products are comprising of many advanced micro/nano composite technologies and few of them might be entering into the market in near future, thereby garnishing the hopes of millions of diabetics who are under the network of s.c. insulin injections.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Insulina Limite: Female / Humans Idioma: En Revista: Crit Rev Ther Drug Carrier Syst Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Insulina Limite: Female / Humans Idioma: En Revista: Crit Rev Ther Drug Carrier Syst Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos